NCT07512869Recruiting
Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Implementation Study
Source: ClinicalTrials.gov · Last updated 6 Apr 2026
Brief summary (registry, in English)
This study evaluates the pre-implementation phase of a host-led harm reduction model for men who have sex with men (MSM) engaging in chemsex in Bangkok, Thailand, focusing on understanding harms, contexts, and needs to develop a tailored intervention.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 76 (estimated)
- First submitted
- 22 Mar 2026
- Start date
- 17 Feb 2025
- Primary completion date
- 17 Feb 2027
- Lead sponsor
- Institute of HIV Research and Innovation Foundation, Thailand
- Diseases
- HIV
- NCT number
- NCT07512869
What you commit to
- Study type: Observational
- Planned participants: 76
- From 17 Feb 2025 to the primary completion date, 17 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unable to provide informed consent (e.g., under substance influence at consent)
Who the study is looking for
- MSM aged ≥18 years
- Able to communicate in Thai
- Specific by group:
- Chemsex hosts: hosted ≥2 times in past 6 months
- Chemsex guests: attended ≥2 times in past 6 months
- CSO / hospital / police staff: working ≥3 months in related roles
- Provide informed consent
Age in the registry: 18 years to - · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tangerine Clinic, Institute of HIV Research and Innovation Coordinator of this site? Confirm its status | Pathum Wan | Thailand | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.